Credit: Image by Katya Kadyshevskaya, courtesy of The Scripps Research Institute.
Researchers at The Scripps Research Institute and Vanderbilt University have achieved an important new understanding of the mGlu1 receptor, a target for future medicines for the treatment of brain disorders.